What is the significance of a low eosinophil count (eosinopenia) and how should it be evaluated in a patient with otherwise normal hemoglobin, hematocrit, white‑cell and platelet counts?

Low Eosinophil Count (Eosinopenia): Clinical Significance and Evaluation

Low eosinophil counts (<0.05-0.1 × 10⁹/L) in a patient with otherwise normal blood counts most commonly indicates acute bacterial infection or sepsis, and should prompt immediate evaluation for infection rather than extensive hematologic workup.

Primary Clinical Significance

Eosinopenia serves as a cost-effective warning marker for bacterial bloodstream infection in hospitalized patients, though it is not sensitive enough to exclude infection when absent 1, 2, 3. The key clinical utility lies in:

Diagnostic Value for Infection

• Significant eosinopenia (≤0.01 × 10⁹/L or ≤10 cells/µL) has high specificity (84-90%) for acute bacterial infection in hospitalized adults 2, 3
• Eosinopenia was present in 71% of patients with confirmed infection versus only 32% in non-infectious inflammatory conditions 3
• In older adults (≥75 years), eosinophil counts of 0-0.07 × 10⁹/L showed independent association with bacterial infection (OR 3.03) 2

Important caveat: C-reactive protein and neutrophil counts remain superior markers for bloodstream infection compared to eosinopenia alone 4. Eosinopenia should be used as a supplementary warning sign, not a standalone diagnostic test.

Prognostic Significance

The dynamic trajectory of eosinophil recovery is more valuable than the absolute count at presentation 1:

• Survivors typically show eosinophil count increases within 2-5 days of hospitalization
• Non-survivors demonstrate persistently low eosinophil levels throughout hospitalization
• This pattern holds across multiple infection types including COVID-19, sepsis, and Clostridioides difficile infection 1

The mortality risk with eosinopenia shows:

• RR 2.35-2.37 for various infections when eosinophils are undetectable (0 cells/mm³) 1
• Mean eosinophil difference between deceased and survivors: -15.31 cells/mm³ for COVID-19 and -44.6 cells/mm³ for sepsis 1

Evaluation Algorithm

Step 1: Assess Clinical Context

Look specifically for:

• Fever, tachycardia, hypotension (sepsis indicators)
• Localized infection signs (pneumonia, urinary symptoms, wound infection)
• Recent corticosteroid use (causes eosinopenia independent of infection) 5
• Acute stress response (surgery, trauma, acute illness—all suppress eosinophils) 5

Step 2: Interpret the Eosinophil Count

• <0.01 × 10⁹/L (<10 cells/µL): Highly specific for bacterial infection; initiate infection workup immediately 2, 3
• 0.01-0.17 × 10⁹/L: Moderate suspicion for infection; correlate with clinical picture
• >0.4 × 10⁹/L: Infection unlikely (only 1.5% of infected patients have counts this high) 3

Step 3: Initial Workup for Suspected Infection

Order:

• Blood cultures (before antibiotics)
• CRP and procalcitonin
• Complete metabolic panel
• Urinalysis and culture
• Chest X-ray if respiratory symptoms
• Site-specific cultures based on clinical presentation

Step 4: Monitor Eosinophil Trajectory

• Recheck eosinophil count at 48-72 hours and day 5
• Rising counts suggest appropriate response to therapy
• Persistently low counts indicate poor prognosis and may warrant treatment escalation 1, 3

Common Pitfalls to Avoid

1. Do not rely on eosinopenia alone to diagnose infection—it has only moderate sensitivity (47-54%) 4. Absence of eosinopenia does not exclude serious bacterial infection.

2. Consider confounding factors 5:

   • Corticosteroids (even topical or inhaled in high doses)
   • Acute stress response from any cause
   • Recent surgery or trauma
   • Cushing's syndrome

3. Do not pursue extensive hematologic workup in acute settings with clear infectious etiology. Eosinopenia from infection resolves with treatment.

4. Pediatric populations: Eosinopenia has poor predictive value in children (sensitivity 54%, specificity 56%) and should not guide clinical decisions 4.

When Hematology Referral IS Indicated

Refer to hematology only if:

• Eosinopenia persists >3 months after infection resolution
• Associated with other unexplained cytopenias
• Evidence of bone marrow failure or malignancy suspected
• No identifiable cause after thorough evaluation

In the acute setting with isolated eosinopenia and normal other counts, focus exclusively on identifying and treating infection rather than pursuing hematologic diagnoses 1, 2, 3.